Please use this identifier to cite or link to this item: http://dx.doi.org/10.14279/depositonce-11506
For citation please use:
Main Title: Das Potenzial von RiPPs in medizinisch-biotechnologischen Anwendungen
Author(s): Hegemann, Julian D.
Type: Article
URI: https://depositonce.tu-berlin.de/handle/11303/12706
http://dx.doi.org/10.14279/depositonce-11506
License: https://creativecommons.org/licenses/by/4.0/
Abstract: Ribosomally synthesized and post-translationally modified proteins (RiPPs) are an interesting natural product superfamily. Their underlying biosynthetic principles, where recognition sites are strictly separated from the regions that are modified in the substrate, make them interesting for utilization in medicinal and biotechnological applications. Here, the promiscuity of RiPP biosynthetic enzymes will be described for examples from the lasso and lanthipeptide subfamilies and current developments as well as future directions in this field will be discussed.
Subject(s): ribosomal synthetisierte und posttranslational modifizierte Peptide
Biosynthese
Peptid
Anwendung
Medizin
Biotechnologie
RIPPs
biosynthesis
peptide
biotechnology
Issue Date: 14-May-2020
Date Available: 4-Mar-2021
Language Code: de
DDC Class: 570 Biowissenschaften; Biologie
Sponsor/Funder: TU Berlin, Open-Access-Mittel – 2020
Journal Title: Biospektrum
Publisher: SpringerNature
Volume: 26
Issue: 3
Publisher DOI: 10.1007/s12268-020-1368-4
Page Start: 236
Page End: 238
EISSN: 1868-6249
ISSN: 0947-0867
TU Affiliation(s): Fak. 2 Mathematik und Naturwissenschaften » Inst. Chemie » FG Biologische Chemie
Appears in Collections:Technische Universität Berlin » Publications

Files in This Item:
Hegemann_Potenzial_2020.pdf
Format: Adobe PDF | Size: 737.89 kB
DownloadShow Preview
Thumbnail

Item Export Bar

This item is licensed under a Creative Commons License Creative Commons